Your browser doesn't support javascript.
loading
Screening tools to evaluate the neurotoxic potential of botanicals: building a strategy to assess safety.
Kanungo, Jyotshna; Sorkin, Barbara C; Krzykwa, Julie; Mitchell, Constance A; Embry, Michelle; Spencer, Peter; Harry, G Jean; Cannon, Jason; Liu, Fang; McPherson, Christopher A; Gafner, Stefan; Westerink, Remco H S.
Affiliation
  • Kanungo J; Division of Neurotoxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA.
  • Sorkin BC; Office of Dietary Supplements, Division of Program Coordination, Planning, and Strategic Initiatives, U.S. National Institutes of Health, Bethesda, MD, USA.
  • Krzykwa J; Health and Environmental Sciences Institute, Washington, DC, USA.
  • Mitchell CA; Health and Environmental Sciences Institute, Washington, DC, USA.
  • Embry M; Health and Environmental Sciences Institute, Washington, DC, USA.
  • Spencer P; Department of Neurology, School of Medicine, Oregon Health & Science University, Portland, OR, USA.
  • Harry GJ; Mechanistic Toxicology Branch, Division of Translational Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, NC, USA.
  • Cannon J; Purdue Institute for Integrative Neuroscience, Purdue University, West Lafayette, IN, USA.
  • Liu F; Division of Neurotoxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA.
  • McPherson CA; Mechanistic Toxicology Branch, Division of Translational Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, NC, USA.
  • Gafner S; American Botanical Council, Austin, TX, USA.
  • Westerink RHS; Division of Toxicology, Institute for Risk Assessment Sciences (IRAS), Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Expert Opin Drug Metab Toxicol ; 20(7): 629-646, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38984683
ABSTRACT
AREAS COVERED This paper outlines the selection of NAMs, including in vitro assays using primary rat cortical neurons, zebrafish embryos, and Caenorhabditis elegans. These assays aim to assess neurotoxic endpoints such as neuronal activity and behavioral responses. Microelectrode array recordings of rat cortical neurons provide insights into the impact of botanical extracts on neuronal function, while the zebrafish embryos and C. elegans assays evaluate neurobehavioral responses. The paper also provides an account of the selection of botanical case studies based on expert judgment and existing neuroactivity/toxicity information. The proposed battery of assays will be tested with these case studies to evaluate their utility for neurotoxicity screening. EXPERT OPINION The complexity of botanicals necessitates the use of multiple NAMs for effective neurotoxicity screening. This paper discusses the evaluation of methodologies to develop a robust framework for evaluating botanical safety, including complex neuronal models and key neurodevelopmental process assays. It aims to establish a comprehensive screening framework.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Zebrafish / Caenorhabditis elegans / Toxicity Tests / Neurotoxicity Syndromes / Neurons Limits: Animals / Humans Language: En Journal: Expert Opin Drug Metab Toxicol Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Zebrafish / Caenorhabditis elegans / Toxicity Tests / Neurotoxicity Syndromes / Neurons Limits: Animals / Humans Language: En Journal: Expert Opin Drug Metab Toxicol Year: 2024 Document type: Article